The goal of this prospective, randomized, controlled study is to compare remimazolam besilat/sufentanyl and propofol/sufentanyl in patients during colonoscopic polypectomies procedures. Patients undergoing colonoscopic polypectomies in procedural sedation using remimazolam besylate/sufentanyl are circulatory and respiratory as or more stable when compared with propofol/sufentanyl sedation.
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Hemodynamic Stability - Mean Arterial Pressure (MAP)
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Hemodynamic Stability - Systolic and Diastolic Blood Pressure
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Hemodynamic Stability - Heart Rate
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Incidence of Hypotension
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Incidence of Bradycardia
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Respiratory Stability - Oxygen Saturation (SpO₂)
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Incidence of Respiratory Depression
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.